1

Biotechnology Companies in the News Editor’s Note: The home page of the BioNJ Web site provides an up-to-the-minute headline service where readers can access press releases issued by New Jersey-based biotechnology companies. Go to the “New Jersey Biotechnology Company News” section on the BioNJ home page (www.BioNJ.org) to read the latest news. Companies wishing to appear in the Biolines Biotechnology Companies in the News section are encouraged to send their news releases to BioNJ via e-mail at BioNJ@BioNJ.org.

August 2 Celgene Prices $1.5 Billion of Senior Unsecured Notes http://newsroom.celgene.com/press-release/financial/celgene-prices-15-billion-senior-unsecured-notes August 1 NPS Pharmaceuticals Enrolls First Patient in Global Registry Designed to Characterize the Natural History of Hypoparathyroidism http://www.npsp.com/investors-pr?trxml_v=nrd&trxml_nr_id=1843603 Celgene Announces Offering of Senior Unsecured Notes http://newsroom.celgene.com/press-release/financial/celgene-announces-offering-senior-unsecured-notes-0 NPS Pharmaceuticals to Present at Upcoming Conferences http://www.npsp.com/media?trxml_v=nrd&trxml_nr_id=1843919 July 30 Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2013 Second Quarter Financial Results http://finance.yahoo.com/news/lexicon-pharmaceuticals-provides-clinical-pipeline-100000991.html Pacira Pharmaceuticals, Inc. Announces Timing for Second Quarter 2013 Financial Results Webcast and Conference Call http://finance.yahoo.com/news/pacira-pharmaceuticals-inc-announces-timing-103000927.html Antares Pharma Welcomes Robert P. Roche Jr. to Board of Directors http://www.businesswire.com/news/home/20130730005368/en/Antares-Pharma-Welcomes-Robert-P.-Roche-Jr. Cubist Pharmaceuticals to Acquire Optimer Pharmaceuticals http://online.wsj.com/article/PR-CO-20130730-914519.html

2

July 29 Bristol-Myers Squibb and Samsung BioLogics Announce Biopharmaceutical Manufacturing Relationship http://news.bms.com/press-release/partnering-news/bristol-myers-squibb-and-samsung-biologics-announce-biopharmaceutical- July 26 Merck Statement Regarding CHMP Review of Incretin-Based Therapies for Type 2 Diabetes, Including Sitagliptin http://www.mercknewsroom.com/press-release/research-and-development-news/merck-statement-regarding-chmp-review-incretin-based-the MSD Statement Regarding CHMP Review of Incretin-Based Therapies for Type 2 Diabetes, Including Sitagliptin http://www.nasdaq.com/press-release/msd-statement-regarding-chmp-review-of-incretin-based-therapies-for-type-2-diabetes-including-sitagliptin-20130726-00479 ADDING MULTIMEDIA: Forest Laboratories and Pierre Fabre Laboratories Announce FDA Approval of FETZIMA™ for the Treatment of Major Depressive Disorder in Adults http://frx.investorhq.businesswire.com/press-release/corporate-news/forest-laboratories-and-pierre-fabre-laboratories-announce-fda-approval July 25 Celgene Reports Second Quarter 2013 Operating and Financial Results http://newsroom.celgene.com/press-release/corporate/celgene-reports-second-quarter-2013-operating-and-financial-results NPS Pharmaceuticals to Report Second Quarter 2013 Financial Results http://www.npsp.com/investors-pr?trxml_v=nrd&trxml_nr_id=1841099 Catalent Pharma Solutions, Inc. Extends Exchange Offer for 7.875% Senior Notes due 2018 http://www.businesswire.com/news/home/20130725005784/en/Catalent-Pharma-Solutions-Extends-Exchange-Offer-7.875 Advaxis Updates Business Outlook for 2013 http://finance.yahoo.com/news/advaxis-updates-business-outlook-2013-123400401.htmlAdvaxis Updates Business Outlook for 2013 STENTYS Revenues for the First Half of 2013 Up 43% Over Prior Year http://www.businesswire.com/news/home/20130425006106/en/STENTYS-Revenues-Quarter-2013 Up-47-Prior-Year Verified Clinical Trials and SAFE-BioPharma Partner to Improve Clinical Trial Results http://www.businesswire.com/news/home/20130725006300/en/Verified-Clinical-Trials-SAFE-BioPharma-Partner-Improve-Clinical IGI Laboratories Announces 2nd Quarter 2013 Results http://www.businesswire.com/news/home/20130717005929/en/IGI-Laboratories-Hold-Conference-Call-2nd-Quarter

3

U.S. FDA Acknowledges Receipt of Resubmission of the New Drug Application for Investigational Compound Dapagliflozin for the Treatment of Type 2 Diabetes http://news.bms.com/press-release/rd-news/us-fda-acknowledges-receipt-resubmission-new-drug-application-investigational- Bristol-Myers Squibb Reports Second Quarter 2013 Financial Results http://news.bms.com/press-release/financial-news/bristol-myers-squibb-reports-second-quarter-2013-financial-results July 24 Merck Announces FDA Acceptance of New Drug Application for Vorapaxar, Investigational Anti-Thrombotic Medicine http://www.mercknewsroom.com/press-release/research-and-development-news/merck-announces-fda-acceptance-new-drug-application-vora LEO Pharma Inc. Introduces Larger 120g Package Size of Taclonex®(calcipotriene and betamethasone dipropionate) Topical Suspension, 0.005%/0.064% for Treatment of Both Scalp and Body Plaque Psoriasis for up to 8 Weeks http://www.businesswire.com/news/home/20130724006138/en/LEO-Pharma-Introduces-Larger-120g-Package-Size The Medicines Company Reports Second Quarter and First Half 2013 Financial Results http://ir.themedicinescompany.com/phoenix.zhtml?c=122204&p=irol-newsArticle&ID=1840467&highlight= Merck Announces Fourth-Quarter 2013 Dividend http://www.mercknewsroom.com/press-release/corporate-news/merck-announces-fourth-quarter-2013-dividend Cancer Genetics Appoints New Member to Board of Directors http://www.thestreet.com/story/11988413/1/cancer-genetics-appoints-new-member-to-board-of-directors.html July 23 Moberg Pharma and Menarini Extend Distribution Agreement for Kerasal Nail to China http://www.businesswire.com/news/home/20130722006387/en/Moberg-Pharma-Menarini-Extend-Distribution-Agreement-Kerasal Protalex Receives Third Interim Review from Independent Data Safety Monitoring Committee in its Phase 1b Trial of PRTX-100 in Rheumatoid Arthritis http://finance.yahoo.com/news/protalex-receives-third-interim-review-132400491.html Cancer Genetics Launches New Genetic Test For Cervical Cancer Management http://www.businesswire.com/news/home/20130723006083/en/Cancer-Genetics-Launches-Genetic-Test-Cervical-Cancer Best Practices, Performance Technologies Presented at ADSA-ASAS Joint Annual Meeting http://www.mercknewsroom.com/press-release/animal-health/best-practices-performance-technologies-presented-adsa-asas-joint-annual

4

Bristol-Myers Squibb Partners with the Centers for Disease Control Foundation to Increase Awareness of Chronic Hepatitis B on World Hepatitis Day http://news.bms.com/press-release/bristol-myers-squibb-partners-centers-disease-control-foundation-increase-awareness-ch Lexicon to Report Second Quarter Financial Results on July 30, 2013 http://www.lexpharma.com/news/press-releases/2289-lexicon-to-report-second-quarter-financial-results-on-july-30-2013.html Forest Laboratories, Inc. Reports Fiscal Year First Quarter 2014 Diluted Earnings Per Share of $0.09 Including Effect of $0.09 Per Share of Acquisition Amortization http://frx.investorhq.businesswire.com/press-release/corporate-news/forest-laboratories-inc-reports-fiscal-year-first-quarter-2014-diluted- July 19 NovaDel Announces Stockholder Approval of Sale of Substantially All Assets to Suda

Ltd. http://www.businesswire.com/news/home/20130719005885/en/NovaDel-Announces-Stockholder-Approval-Sale-Substantially-Assets July 18 Celgene Will Discontinue Phase III ORIGIN® Trial in Previously Untreated Elderly Patients with B-Cell Chronic Lymphocytic Leukemia http://newsroom.celgene.com/press-release/corporate/celgene-will-discontinue-phase-iii-origin-trial-previously-untreated-elderly New Study Shows Significant Reduction in Opioids, Length of Hospital Stay and Cost of Care for Patients Receiving EXPAREL®as the Foundation of a Multimodal Postsurgical Pain Regimen http://www.businesswire.com/news/home/20130718005795/en/Study-Shows-Significant-Reduction-Opioids-Length-Hospital New Study Shows Significant Reduction in Opioids, Length of Hospital Stay and Cost of Care for Patients Receiving EXPAREL®as the Foundation of a Multimodal Postsurgical Pain Regimen http://www.businesswire.com/news/home/20130718005795/en/Study-Shows-Significant-Reduction-Opioids-Length-Hospital July 17 Advaxis Announces ADXS-cHER2 Demonstrates Significant Survival Advantage in Ongoing Canine Osteosarcoma Study http://www.businesswire.com/news/home/20130717005640/en/Advaxis-Announces-ADXS-cHER2-Demonstrates-Significant-Survival-Advantage Berkley Life Sciences Offers International Insurance Coverage for U.S. Life Science Businesses Through Lloyd’s of London http://www.businesswire.com/news/home/20130717005961/en/Berkley-Life-Sciences-Offers-International-Insurance-Coverage Plaintiffs Amend Previously Dismissed Class Action Lawsuit against Columbia Laboratories http://finance.yahoo.com/news/plaintiffs-amend-previously-dismissed-class-200000476.html

5

July 16 Advaxis Announces Appointment of New Member to Its Board of Directors http://www.businesswire.com/news/home/20130716005484/en/Advaxis-Announces-Appointment-Member-Board-Directors Immunomedics Constructs New Humanized Antibody for B-Cell Mediated Cancer and Autoimmune Diseases http://finance.yahoo.com/news/immunomedics-constructs-humanized-antibody-b-123000679.html Merck Statement on FDA Advisory Committee Meeting About Sugammadex Sodium Injection http://www.mercknewsroom.com/press-release/research-and-development-news/merck-statement-fda-advisory-committee-meeting-about-sug July 15 Advaxis Announces 1-for-125 Reverse Stock Split and Decrease in Authorized Shares of Common Stock http://finance.yahoo.com/news/advaxis-announces-1-125-reverse-123000565.html 2013 R&D 100 Awards Winners Announced http://www.rdmag.com/news/2013/07/2013-r-d-100-awards-winners-announced?qt-recent_blogs_articles=1 July 14 Merck Presents Findings from Phase 1b Study of Investigational BACE Inhibitor, MK-8931, in Patients with Alzheimer’s Disease http://www.mercknewsroom.com/press-release/alzheimers-disease/merck-presents-findings-phase-1b-study-investigational-bace-inhibit July 12 Vasospasm 2013 Conference Features Oral Presentation of Edge Therapeutics’ EG-1962 http://www.businesswire.com/news/home/20130712005054/en/Vasospasm-2013-Conference-Features-Oral-Presentation-Edge July 11 FDA Accepts Eliquis® (apixaban) Supplemental New Drug Application for Review for Prophylaxis of Deep Vein Thrombosis Following Hip Or Knee Replacement Surgery http://news.bms.com/press-release/rd-news/fda-accepts-eliquis-apixaban-supplemental-new-drug-application-review-prophyla CNBC Ranks New Jersey #1 State for Education http://www.cnbc.com/id/100824779?utm_source=Jersey+Byte+7%2F10%2F2013&utm_campaign=Jersey+Byte+7%2F1%2F2013&utm_medium=email Phase III Study (MM-020/IFM 07-01) of Oral REVLIMID® (Lenalidomide) in Newly-Diagnosed Multiple Myeloma Meets Primary Endpoint http://newsroom.celgene.com/press-release/corporate/phase-iii-study-mm-020ifm-07-01-oral-revlimid-lenalidomide-newly-diagnosed-m July 10 Celldex Therapeutics Announces Issuance of Seminal Patent for CD27 Agonists http://ir.celldextherapeutics.com/releasedetail.cfm?ReleaseID=776074

6

STENTYS Self-Apposing Stent Approved in Europe for Additional Coronary Indications http://www.businesswire.com/news/home/20130710006022/en/STENTYS-Self-Apposing-Stent-Approved-Europe-Additional-Coronary July 9 Vention Medical Acquires RiverTech Medical http://www.businesswire.com/news/home/20130709005903/en/Vention-Medical-Acquires-RiverTech-Medical July 8 Soligenix Announces Commercial Collaboration with SciClone Pharmaceuticals in China for SGX942 in the Treatment of Oral Mucositis http://www.soligenix.com/news.aspx?titleId=425 Saint-Gobain Performance Plastics New Chromatography Assemblies Provide Custom-Quality Sample Packaging at an Economical Price http://finance.yahoo.com/news/saint-gobain-performance-plastics-chromatography-110000686.html Celgene Corporation to Announce Second Quarter 2013 Results on July 25, 2013 http://newsroom.celgene.com/press-release/financial/celgene-corporation-announce-second-quarter-2013-results-july-25-2013 July 5 CorMedix Receives CE Mark for Neutrolin® Catheter Lock Solution http://cormedix.com/news_July_5_2013.php July 3 Immunomedics Reports First Results From Phase IB Study of 90Y-Clivatuzumab In Patients With Metastatic Pancreatic Cancer After 2 or More Prior Therapies http://www.nbcnews.com/id/52383689/ns/business-press_releases/t/immunomedics-reports-first-results-phase-ib-study-y-clivatuzumab-patients-metastatic-pancreatic-cancer-after-or-more-prior-therapies/ SK Biopharmaceuticals and AriBio Enter into a Strategic Alliance http://finance.yahoo.com/news/sk-biopharmaceuticals-aribio-enter-strategic-165600994.html July 2 Celator® Pharmaceuticals to Present at JMP Securities Healthcare Conference http://www.businesswire.com/news/home/20130702006159/en/Celator%C2%AE-Pharmaceuticals-Present-JMP-Securities-Healthcare-Conference The Medicines Company Announces Positive Results for Solo II Trial of Oritavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) http://ir.themedicinescompany.com/phoenix.zhtml?c=122204&p=irol-newsArticle&ID=1834647&highlight= July 1 Columbia Labs Relocates to Boston http://www.columbialabs.com/a0b90603-38fc-40e9-8c01-d9e7ec5512a9/investors-press-releases-2012-details.htm

7

FDA Accepts the Filing of The Medicines Company's New Drug Application for Intravenous Antiplatelet Agent Cangrelor http://finance.yahoo.com/news/fda-accepts-filing-medicines-companys-120000484.html Alliance for Biosecurity Elects Chief Executive Officers of Bavarian Nordic and Elusys Therapeutics As New Co-Chairs http://www.elusys.com/press_releases13/070113.html Celldex Therapeutics Initiates Pilot Study in Dense Deposit Disease http://ir.celldextherapeutics.com/releasedetail.cfm?ReleaseID=774822 June 28 Bard to Divest Electrophysiology Business http://finance.yahoo.com/news/bard-divest-electrophysiology-business-123000012.html Soligenix Completes Phase 1 Clinical Study with SGX203 for the Treatment of Pediatric Crohn's Disease http://www.soligenix.com/news.aspx?titleId=424 June 27 Edge Therapeutics Reports Positive Early Clinical Experience with EG-1962 to Prevent Serious Complications after Brain Hemorrhage http://www.businesswire.com/news/home/20130627005590/en/Edge-Therapeutics-Reports-Positive-Early-Clinical-Experience Antares Pharma Announces the Issuance of a New U. S. Patent for OTREXUP™ http://www.antarespharma.com/files/4813/6611/7283/DiscontinCollar_Patent_Issue.pdf NovaDel Announces Adjournment of Special Stockholder Meeting http://www.bioportfolio.com/news/article/1545261/NovaDel-Announces-Adjournment-of-Special-Stockholder-Meeting.html June 26 Soligenix Closes $7.1 Million Public Offering http://www.soligenix.com/news.aspx?titleId=423 InnovoCommerce/SAFE-BioPharma Form Strategic Relationship http://www.businesswire.com/news/home/20130626006064/en/InnovoCommerceSAFE-BioPharma-Form-Strategic-Relationship MorphoSys and Celgene Create Strategic Alliance to Advance CD38 Cancer Program MOR202 for Patients with Multiple Myeloma http://finance.yahoo.com/news/morphosys-celgene-create-strategic-alliance-214518918.html June 25 Amicus Therapeutics Announces Chaperone-Advanced Replacement Therapy in Development for Mucopolysaccharidosis Type I (MPS I) http://ir.amicustherapeutics.com/releasedetail.cfm?ReleaseID=773477 PTC Therapeutics Closes Initial Public Offering http://ir.ptcbio.com/releasedetail.cfm?ReleaseID=773602

8

June 24 Lexicon Presents Data at the American Diabetes Association Meeting On Blood Pressure Reduction and Weight Loss In Clinical Trial of LX4211 http://finance.yahoo.com/news/lexicon-presents-data-american-diabetes-120000697.html Lexicon Presents Preclinical Data on LX2761, a New Clinical Candidate for Diabetes Designed to Reduce Glucose Absorption from Gastrointestinal Tract http://www.lexpharma.com/news/press-releases/2287-lexicon-presents-preclinical-data-on-lx2761-a-new-clinical-candidate-for-diabetes-designed-to-reduce-glucose-absorption-from-gastrointestinal-tract.html Exalenz Bioscience Names Ted Foltyn New VP of Worldwide Marketing and Business Development http://www.businesswire.com/news/home/20130624005677/en/Exalenz-Bioscience-Names-Ted-Foltyn-VP-Worldwide Advaxis Requests Orphan Drug Designation for Treatment of HPV-Associated Anal Cancer with ADXS-HPV http://www.businesswire.com/news/home/20130607005331/en/Advaxis-Requests-Orphan-Drug-Designation-Treatment-Cervical Paragon Solutions and Microsoft Co-Author SharePoint 2013 Version of Compliance Whitepaper http://www.businesswire.com/news/home/20110215006718/en/Paragon-Solutions-Microsoft-Co-Author-Whitepaper-Detailing-SharePoint June 21 Soligenix Announces Pricing of Public Offering of Common Stock and Warrants http://www.soligenix.com/news.aspx?titleId=421 June 20 PTC Therapeutics Prices Initial Public Offering http://ir.ptcbio.com/ReleaseDetail.cfm?ReleaseID=772573 Two Studies Evaluating the Combination of REVLIMID® and rituximab in Non-Hodgkin’s Lymphomas Presented at International Conference on Malignant Lymphoma http://newsroom.celgene.com/press-release/product/two-studies-evaluating-combination-revlimid-and-rituximab-non-hodgkins-lymphom FDA Approves U.S. Product Labeling Update for Sprycel®(dasatinib) to Include Three-Year First-Line and Five-Year Second-Line Efficacy and Safety Data in Chronic Myeloid Leukemia in Chronic Phase http://www.dailyfinance.com/2013/06/20/fda-approves-us-product-labeling-update-for-spryce/ Zoetis™ Declares Third-Quarter 2013 Dividend http://www.zoetis.com/news-media/press-releases/zoetis%E2%84%A2-declares-third-quarter-2013-dividend?index=0&ref=news-media/press-releases/most_recent&view=press_releases%3Alist%3Aattachment_1 Food science: Taste bud hackers

http://www.nature.com/nature/journal/v486/n7403_supp/full/486S14a.html

9

June 19 Senesco Announces Results of Cohort 2 of its SNS01-T Phase 1b/2a Trial http://www.businesswire.com/news/home/20130506005702/en/Senesco-Announces-Start-Cohort-3-Phase-1b2a AstraZeneca and Bristol-Myers Squibb Announce Top Line Results for SAVOR-TIMI-53 Cardiovascular Outcomes Trial of Onglyza® (saxagliptin) http://news.bms.com/press-release/astrazeneca-and-bristol-myers-squibb-announce-top-line-results-savor-timi-53-cardiovas Bristol-Myers Squibb Announces Dividend http://news.bms.com/press-release/financial-news/bristol-myers-squibb-announces-dividend-16 Bristol-Myers Squibb Names Dinesh C. Paliwal to Board of Directors http://news.bms.com/press-release/financial-news/bristol-myers-squibb-names-dinesh-c-paliwal-board-directors Curie-Cancer and Sanofi cooperate in research on ovarian cancer http://en.sanofi.com/Images/33182_20130619_SANOFI-CURIE_en.pdf TKL Research is Building New Clinical Research Facility in Fair Lawn, N.J. http://finance.yahoo.com/news/tkl-research-building-clinical-research-114500390.html Astellas Pharma Inc. Is First Japanese Pharma Company to Join SAFE-BioPharma http://finance.yahoo.com/news/astellas-pharma-inc-first-japanese-114800838.html IMS Health Study Identifies $200+ Billion Annual Opportunity from Using Medicines More Responsibly http://www.imshealth.com/portal/site/imshealth/menuitem.c76283e8bf81e98f53c753c71ad8c22a/?vgnextoid=12531cf4cc75f310VgnVCM10000076192ca2RCRD&vgnextchannel=5ec1e590cb4dc310VgnVCM100000a48d2ca2RCRD&vgnextfmt=default Senesco Announces Results of Cohort 2 of its SNS01-T Phase 1b/2a Trial http://www.businesswire.com/news/home/20130619005605/en/Senesco-Announces-Results-Cohort-2-SNS01-T-Phase June 18 Bristol-Myers Squibb Grants Help K-12 Educators Bring Science to Life and Help Students Explore Their Interests in the Sciences and Science-Based Careers http://news.bms.com/press-release/philanthropy-news/bristol-myers-squibb-grants-help-k-12-educators-bring-science-life-a ADMA Biologic’s Plasma Collection Facility Receives GHA Certification for the Sale of Source Plasma in Europe http://www.businesswire.com/news/home/20130618005218/en/ADMA-Biologic%E2%80%99s-Plasma-Collection-Facility-Receives-GHA John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations http://finance.yahoo.com/news/john-northcott-joins-lexicon-vice-100000499.html

10

Oral Anti-Cancer Therapy Revlimid® (Lenalidomide) Now Indicated as a Treatment for Patients with Rare Form of Blood Disease http://newsroom.celgene.com/press-release/oral-anti-cancer-therapy-revlimid-lenalidomide-now-indicated-treatment-patients-rare-f Sanofi to present new clinical data, including results from the investigational new insulin U300, at the American Diabetes Association 73rd Scientific Sessions http://en.sanofi.com/Images/33175_20130618_ADA2013CURTAINRAISER_en.pdf June 17 SwabCap and SwabFlush Are Focus of Three Studies at APIC Conference http://www.businesswire.com/news/home/20130617005326/en/SwabCap-SwabFlush-Focus-Studies-APIC-Conference Initial Findings from PARADOX, Largest and Most Comprehensive Research Analyzing the Burden of Hypoparathyroidism, Reveals Collection of Nearly 40 Physical, Cognitive, Emotional Symptoms http://npsp.com/investors-pr?trxml_v=nrd&trxml_nr_id=1830235 Findings Presented at ENDO 2013 Support Therapeutic Potential of Natpara® as Parathyroid Hormone Replacement Therapy in Patients with Hypoparathyroidism http://npsp.com/investors-pr?trxml_v=nrd&trxml_nr_id=1830234 Advaxis Announces Voting Results of 2013 Annual Meeting of Stockholders http://www.businesswire.com/news/home/20130617005466/en/Advaxis-Announces-Voting-Results-2013-Annual-Meeting QPharma Appoints Senior Manager, Healthcare Compliance http://www.businesswire.com/news/home/20130617006154/en/QPharma-Appoints-Senior-Manager-Healthcare-Compliance Amicus Therapeutics to Host Conference Call Today at 8:00 a.m. ET to Discuss Regulatory Strategy for Migalastat HCl Monotherapy for Fabry Disease http://ir.amicustherapeutics.com/releasedetail.cfm?ReleaseID=771675 June 15 Bristol-Myers Squibb and AbbVie Announce Progression-Free Survival Data from Phase 2 Open-Label Study of Investigational Agent Elotuzumab in Combination with Lenalidimide and Dexamethasone in Previously-Treated Multiple Myeloma http://news.bms.com/press-release/rd-news/bristol-myers-squibb-and-abbvie-announce-progression-free-survival-data-phase- June 14 Immunomedics to Present at Wells Fargo Securities 2013 Healthcare Conference http://finance.yahoo.com/news/immunomedics-present-wells-fargo-securities-123000214.html Bristol-Myers Squibb and Simcere Enter Partnership to Co-Develop and Co-Commercialize Orencia® SC (abatacept) in China http://news.bms.com/press-release/bristol-myers-squibb-and-simcere-enter-partnership-co-develop-and-co-commercialize-ore

11

NPS Pharmaceuticals’ President and CEO Dr. Francois Nader Receives Ernst & Young Entrepreneur Of The Year® 2013 Award in New Jersey http://npsp.com/investors-pr?trxml_v=nrd&trxml_nr_id=1829968 Onconova Files Registration Statement for Proposed Initial Public Offering of Common Stock http://www.businesswire.com/news/home/20130614005902/en/Onconova-Files-Registration-Statement-Proposed-Initial-Public June 13 Immunomedics Reports That UCB Announces New Results From Phase 2B Open-Label Extension Study Evaluating the Long-Term Effects of Epratuzumab in SLE http://www.nasdaq.com/article/immunomedics-reports-that-ucb-announces-new-results-from-phase-2b-open-label-extension-study-evaluating-the-long-term-effects-of-epratuzumab-in-sle-20130613-00332 Immunomedics Presents Epratuzumab’s Mechanism of Action in Systemic Lupus Erythematosus http://www.nasdaq.com/article/immunomedics-presents-epratuzumabs-mechanism-of-action-in-systemic-lupus-erythematosus-20130613-00396 37 African-American Students Awarded Prestigious UNCF•Merck Science Initiative Scholarships and Fellowships in Biosciences http://www.marketwatch.com/story/37-african-american-students-awarded-prestigious-uncfmerck-science-initiative-scholarships-and-fellowships-in-biosciences-2013-06-13 Subcutaneous, Self-Administered Methotrexate for Rheumatoid Arthritis Demonstrated Significantly Greater Bioavailability Over Current Standard Of Care http://www.antarespharma.com/files/8613/7112/9161/DEVICE_EULAR_Poster_Press_Release_June_12.pdf Data from Phase III Randomized Controlled Study (PALACE 3) of Apremilast in Psoriatic Arthritis Presented at EULAR http://newsroom.celgene.com/press-release/corporate/data-phase-iii-randomized-controlled-study-palace-3-apremilast-psoriatic-art June 12 Immunomedics Reports Progress With Labeling Proteins, Including Antibodies, for Improved Pet Imaging http://finance.yahoo.com/news/immunomedics-reports-progress-labeling-proteins-170000610.html Derma Sciences Reports Results from DSC127 Pharmacokinetic Study http://phx.corporate-ir.net/phoenix.zhtml?c=107533&p=RssLanding&cat=news&id=1829106 Published Research Concludes Total Contact Casting is More Effective in Healing Diabetic Foot Ulcers Than Other Standards of Care http://www.businesswire.com/news/home/20130612005363/en/Published-Research-Concludes-Total-Contact-Casting-Effective Signs and Symptoms of Psoriatic Arthritis Significantly Improved in Patients Receiving Long-Term Oral Apremilast Treatment in Phase III Study (PALACE-1) http://www.stockhouse.com/news/usreleasesdetail.aspx?n=8896608

12

Merck Welcomes Independent Review of the Safety Profile of JANUVIA® (sitagliptin) and Other Diabetes Medicines http://www.mercknewsroom.com/press-release/prescription-medicine-news/merck-welcomes-independent-review-safety-profile-januvia-si Celgene Announces Additional $3.0 Billion Share Repurchase Program http://newsroom.celgene.com/press-release/financial/celgene-announces-additional-30-billion-share-repurchase-program AstraZeneca and Bristol-Myers Squibb Statement on Proposal by the American Diabetes Association for Independent Review of Incretin-Based Therapies http://news.bms.com/press-release/astrazeneca-and-bristol-myers-squibb-statement-proposal-american-diabetes-association- Hurley Consulting Associates Ltd. Announces Appointment of John C. Talian, Ph.D. as Vice President, Regulatory Affairs http://finance.yahoo.com/news/hurley-consulting-associates-ltd-announces-214500725.html June 11 Vertical Pharmaceuticals, Inc. Announces New Co-promote Agreement for Lorzone™ (Chlorzoxazone Tablets, USP) http://finance.yahoo.com/news/vertical-pharmaceuticals-inc-announces-co-113000260.html Combination of 90Y-epratuzumab and veltuzumab is active in NHL http://finance.yahoo.com/news/combination-90y-epratuzumab-veltuzumab-active-123000264.html June 10 New data from epratuzumab to be presented at EULAR 2013 http://www.nasdaq.com/article/new-data-from-epratuzumab-to-be-presented-at-eular-2013-20130610-00007 FDA Accepts IND Application For Edge Therapeutics’ EG-1962 (nimodipine microparticles) http://finance.yahoo.com/news/fda-accepts-ind-application-edge-103000779.html Advaxis Issues Letter Advising Stockholders to Vote FOR Proposals 2 and 3 of Proxy Statement http://finance.yahoo.com/news/advaxis-issues-letter-advising-stockholders-132000219.html To put revenue in rare form, a focus on uncommon disease http://www.njbiz.com/apps/pbcs.dll/article?AID=/20130610/NJBIZ01/306079992/To-put-revenue-in-rare-form-a-focus-on-uncommon-disease&utm_source=Listrak&utm_medium=Email&utm_term=http%3a%2f%2fwww.njbiz.com%2farticle%2f20130610%2fNJBIZ01%2f306079992%2fTo-put-revenue-in-rare-form-a-focus-on-uncommon-disease&utm_campaign=Central+Jersey+Report/&template=printart June 7 Lexicon To Present At The Goldman Sachs Global Healthcare Conference http://finance.yahoo.com/news/lexicon-present-goldman-sachs-global-100000386.html

13

Advaxis Requests Orphan Drug Designation for Treatment of Cervical Cancer with ADXS-HPV http://finance.yahoo.com/news/advaxis-requests-orphan-drug-designation-120000018.html The Medicines Company to Participate in Goldman Sachs 34th Annual Global Healthcare Conference http://ir.themedicinescompany.com/phoenix.zhtml?c=122204&p=irol-newsArticle&ID=1828028&highlight= June 6 Advaxis Announces Withdrawal of Proxy Statement Proposal to Amend Its Incentive Plan at This Time http://www.businesswire.com/news/home/20130606005627/en/Advaxis-Announces-Withdrawal-Proxy-Statement-Proposal-Amend Celgene Corporation to Webcast at Upcoming Investor Conference http://newsroom.celgene.com/press-release/corporate/celgene-corporation-webcast-upcoming-investor-conference Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program http://finance.yahoo.com/news/aegerion-pharmaceuticals-grants-stock-options-123000325.html Lexicon to Present at the Goldman Sachs Global Healthcare Conference http://www.lexpharma.com/news/press-releases/2283-lexicon-to-present-at-the-goldman-sachs-global-healthcare-conference.html June 5 NPS Pharmaceuticals to Present Data from NatparaTM REPLACE Study and PARADOX Study at ENDO 2013, The Endocrine Society's 95th Annual Meeting http://www.npsp.com/investors-pr?trxml_v=nrd&trxml_nr_id=1827205 U.S. Food and Drug Administration Approves REVLIMID®(lenalidomide) for the Treatment of Patients with Relapsed or Refractory Mantle Cell Lymphoma http://finance.yahoo.com/news/u-food-drug-administration-approves-170000767.html June 4 Advaxis Announces Amendment of Proxy Statement Supplement Further Reduction in Share Capital Proposal http://www.businesswire.com/news/home/20130604006020/en/Advaxis-Announces-Amendment-Proxy-Statement-Supplement-Reduction U.S. FDA Grants Priority Review to Bristol-Myers Squibb and AstraZeneca’s Metreleptin, an Investigational Agent for Treatment of Metabolic Disorders Associated with Rare Forms of Lipodystrophy http://news.bms.com/press-release/us-fda-grants-priority-review-bristol-myers-squibb-and-astrazenecas-metreleptin-invest Edge Therapeutics Raises $18 Million to Advance Clinical Development of Potentially Life-Saving Hospital Products http://www.biomedreports.com/20130604138994/edge-therapeutics-raises-$18-million-to-advance-clinical-development-of-potentially-life-saving-hospital-products.html

14

Bard Announces First Patient Enrolled in Lutonix Below the Knee (BTK) Clinical Trial http://crbard.com/prlanding.aspx?releaseID=1826893 Bayer Seeing Early Returns on Investment in Oncology http://www.njbiz.com/article/20130604/NJBIZ01/130609947?utm_source=listrak&utm_medium=Daily&utm_term=Daily%2BNews&utm_campaign=Daily%2BNews&utm_source=Listrak&utm_medium=Email&utm_term=http%3a%2f%2fwww.njbiz.com%2farticle%2f20130604%2fNJBIZ01%2f130609947%3futm_source%3dlistrak%26utm_medium%3dDaily%26utm_term%3dDaily%252BNews%26utm_campaign%3dDaily%252BNews&utm_campaign=The+Daily%3a+Prudential%27s+office+plan%2c+utility%27s+social+Sandy+strategy%2c+ramping+up+retail Medicines Co. acquisition of ProFibrix Depends on Study http://www.njbiz.com/article/20130604/NJBIZ01/130609952?utm_source=listrak&utm_medium=Daily&utm_term=Daily%2BNews&utm_campaign=Daily%2BNews&utm_source=Listrak&utm_medium=Email&utm_term=http%3a%2f%2fwww.njbiz.com%2farticle%2f20130604%2fNJBIZ01%2f130609952%3futm_source%3dlistrak%26utm_medium%3dDaily%26utm_term%3dDaily%252BNews%26utm_campaign%3dDaily%252BNews&utm_campaign=The+Daily%3a+Prudential%27s+office+plan%2c+utility%27s+social+Sandy+strategy%2c+ramping+up+retail The Medicines Company Signs Agreement to Acquire ProFibrix http://ir.themedicinescompany.com/phoenix.zhtml?c=122204&p=irol-newsArticle&ID=1826658&highlight= June 3 Study Evaluating REVLIMID® Combination Compared to Autologous Stem Cell Transplant with or without REVLIMID Maintenance in Newly-Diagnosed Multiple Myeloma Presented at ASCO http://newsroom.celgene.com/press-release/product/study-evaluating-revlimid-combination-compared-autologous-stem-cell-transplant Celator® Pharmaceuticals Announces New Data on Factors Associated with Outcomes in AML Patients Treated with CPX-351 http://www.businesswire.com/news/home/20130603005499/en/Celator%C2%AE-Pharmaceuticals-Announces-Data-Factors-Outcomes-AML FDA Grants Soligenix "Fast Track" Designation for SGX942 for the Treatment of Oral Mucositis in Patients with Head and Neck Cancer http://www.soligenix.com/news.aspx?titleId=420 Octapharma USA President Flemming Nielsen Named Humanitarian Man of the Year by Hemophilia Association of NJ http://www.businesswire.com/news/home/20130603005100/en/Octapharma-USA-President-Flemming-Nielsen-Named-Humanitarian Analyses of MPACT Trial Evaluating ABRAXANE® Combination Therapy for the Treatment of Advanced Pancreatic Cancer Presented at ASCO 2013 http://www.dailyfinance.com/2013/06/03/analyses-of-mpact-trial-evaluating-abraxane-combin/ DSP Clinical Earns Certification as Women’s Business Enterprise (WBE) from Women’s Business Enter prise National Council (WBENC) http://www.businesswire.com/news/home/20130603006444/en/DSP-Clinical-Earns-Certification-Women%E2%80%99s-Business-Enterprise

15

PTC Therapeutics Appoints Shane Kovacs as Chief Financial Officer http://ir.ptcbio.com/ReleaseDetail.cfm?ReleaseID=768504 June 2 Bristol-Myers Squibb Announces Phase 1 Results from First Trial Combining Immune Checkpoint Inhibitors, Investigational Agent Nivolumab and Yervoy® (ipilimumab), in Patients with Advanced Melanoma http://news.bms.com/press-release/rd-news/bristol-myers-squibb-announces-phase-1-results-first-trial-combining-immune-ch Advaxis Reports Survival and New Analysis for ADXS-HPV in Patients with Recurrent Cervical Cancer at the 2013 American Society of Clinical Oncology Annual Meeting http://www.nasdaq.com/article/advaxis-reports-survival-and-new-analysis-for-adxs-hpv-in-patients-with-recurrent-cervical-cancer-at-the-2013-american-society-of-clinical-oncology-annual-meeting-20130602-00037 Merck Announces Presentation of Interim Data from Study Evaluating Lambrolizumab, an Investigational Anti-PD-1 Antibody, in Patients with Advanced Melanoma at ASCO 2013 http://www.mercknewsroom.com/press-release/research-and-development-news/merck-announces-presentation-interim-data-study-evaluati May 31 Lexicon to Present at The Jefferies Global Healthcare Conference http://www.lexicon-genetics.com/news/press-releases/2281-lexicon-to-present-at-the-jefferies-global-healthcare-conference.html NPS Pharmaceuticals Joins the Hypoparathyroidism Association in Recognition of World Hypoparathyroidism Awareness Day http://www.npsp.com/media?trxml_v=nrd&trxml_nr_id=1825867 GE Healthcare Announces Commercial Availability of New Methodology That Provides a Cancer Profile on a Single Slide http://finance.yahoo.com/news/ge-healthcare-announces-commercial-availability-130000705.html Celgene Announces Launch of “Innovation Impact” Awards to Recognize Excellence in Creative Patient, Caregiver or Healthcare Provider Programs http://newsroom.celgene.com/press-release/celgene-announces-launch-innovation-impact-awards-recognize-excellence-creative-patien Oral Anti-Cancer Therapy Pomalidomide Celgene Receives Positive CHMP Opinion as Treatment for Patients with Relapsed and Refractory Multiple Myeloma http://newsroom.celgene.com/press-release/oral-anti-cancer-therapy-pomalidomide-celgene-receives-positive-chmp-opinion-treatment CorMedix Granted Extension of NYSE MKT Listing http://finance.yahoo.com/news/cormedix-granted-extension-nyse-mkt-121500204.html May 30 Symphogen to Report New Data on Anti-EGFR Monoclonal Antibody Mixture at ASCO http://www.businesswire.com/news/home/20130530005457/en/Symphogen-Report-Data-Anti-EGFR-Monoclonal-Antibody-Mixture

16

Octapharma Leading Corporate Sponsor of Save One Life http://www.octapharma.com/en/about-octapharma/news-events/news-single-view.html?tx_ttnews%5Btt_news%5D=327&cHash=62c1069a0b12d2ffad116eff82d246fc May 29 Pacira Pharmaceuticals, Inc. Announces Positive Interim Analysis of EXPAREL in Femoral Nerve Block for Total Knee Arthroplasty http://finance.yahoo.com/news/pacira-pharmaceuticals-inc-announces-positive-103000635.html Antares Pharma to Present at the Jefferies 2013 Global Healthcare Conference http://finance.yahoo.com/news/antares-pharma-present-jefferies-2013-110000124.html Regulatory Harmonization Institute Workshop for U.S. – Japan Health Care Study Group: Emerging Markets Present Opportunities for Collaboration and Innovative Partnerships http://www.businesswire.com/news/home/20130529006261/en/Regulatory-Harmonization-Institute-Workshop-U.S.-%E2%80%93-Japan CLICK HERE to return to the main page.